Eton Pharmaceuticals (ETON) awards 128,985 performance RSUs to its CEO
Rhea-AI Filing Summary
BRYNJELSEN SEAN reported acquisition or exercise transactions in this Form 4 filing.
Eton Pharmaceuticals, Inc. granted President & CEO Sean Brynjelsen 128,985 performance-vested restricted stock units under its 2018 equity incentive plan on July 31, 2026.
Each unit represents one common share and vests only if the stock’s closing price reaches at least $72.36 for one trading day before the third anniversary of the grant; otherwise the entire award is forfeited without payment on July 31, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
BRYNJELSEN SEAN
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 128,985 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 128,985 shares (Direct)
Footnotes (1)
- F1. On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Key Figures
Performance RSUs granted: 128,985 units
Stock price vesting condition: $72.36 per share
Maximum shares issuable under award: 128,985 shares
+2 more
5 metrics
Performance RSUs granted
128,985 units
Grant to President & CEO on July 31, 2026
Stock price vesting condition
$72.36 per share
Closing price required for one trading day for vesting
Maximum shares issuable under award
128,985 shares
Footnote states this is the maximum and only number issuable
Grant date
July 31, 2026
Date the performance-vested restricted stock units were granted
Forfeiture date if condition unmet
July 31, 2029
Date on which the entire award is forfeited without consideration
Key Terms
performance-vested restricted stock units, equity incentive plan, market condition
3 terms
performance-vested restricted stock units financial
"the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan"
equity incentive plan financial
"restricted stock units granted under the Issuer's 2018 equity incentive plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
market condition financial
"If this market condition is not satisfied prior to such date, the award will be forfeited"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Eton Pharmaceuticals (ETON) grant its CEO?
Eton Pharmaceuticals granted its President & CEO 128,985 performance-vested restricted stock units. Each unit entitles him to receive one share of common stock if a specified stock-price condition is met within the defined performance period.
What stock price must ETON reach for the 128,985 RSUs to vest?
The RSUs vest only if Eton’s common stock closing price equals or exceeds $72.36 per share for one trading day. This stock-price hurdle is a market condition that must be satisfied before the third anniversary of the July 31, 2026 grant.
By when must Eton Pharmaceuticals (ETON) satisfy the market condition for this grant?
The market condition must be satisfied before the third anniversary of the July 31, 2026 grant date. If it is not met by then, the award is scheduled to be forfeited in full on July 31, 2029.
What happens to the 128,985 ETON RSUs if the $72.36 condition is not met?
If the $72.36 per share market condition is not achieved in the required period, the entire 128,985-unit award will be forfeited without consideration on July 31, 2029. No shares will be issued and no value will be paid to the CEO.
Is there a performance range or target structure for ETON’s CEO RSU grant?
No. The footnote states the 128,985 shares reported are the maximum and only number issuable under the award. It also clarifies there is no target, threshold, or maximum performance range; the grant is all-or-nothing based on the market condition.